Advertisement
Advertisement
U.S. Markets open in 9 hrs 3 mins
Advertisement
Advertisement
Advertisement
Advertisement

Quoin Pharmaceuticals, Ltd. (QNRX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
1.8300+0.0500 (+2.81%)
At close: 12:56PM EST
1.8000 -0.03 (-1.64%)
After hours: 04:37PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 11/28/2022
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 364.3750
52 Week Low 31.5700
50-Day Moving Average 32.1880
200-Day Moving Average 37.7689

Share Statistics

Avg Vol (3 month) 31.23M
Avg Vol (10 day) 360.74k
Shares Outstanding 58.35M
Implied Shares Outstanding 6N/A
Float 84.27M
% Held by Insiders 12.42%
% Held by Institutions 17.85%
Shares Short (Oct 13, 2022) 433.92k
Short Ratio (Oct 13, 2022) 40.13
Short % of Float (Oct 13, 2022) 4N/A
Short % of Shares Outstanding (Oct 13, 2022) 40.70%
Shares Short (prior month Sep 14, 2022) 4238.79k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Oct 22, 2019
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-157.30%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -9.02M
Net Income Avi to Common (ttm)-17.57M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.69M
Total Cash Per Share (mrq)0.56
Total Debt (mrq)4.42M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.96
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-8.33M
Levered Free Cash Flow (ttm)-10.14M
Advertisement
Advertisement